High anticancer potency on tumor cells of dehydroabietylamine Schiff-base derivatives and a copper(II) complex.

[1]  A. Riyasdeen,et al.  DNA and protein binding, double-strand DNA cleavage and cytotoxicity of mixed ligand copper(II) complexes of the antibacterial drug nalidixic acid. , 2017, Journal of inorganic biochemistry.

[2]  Ri-zhen Huang,et al.  Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents. , 2017, European journal of medicinal chemistry.

[3]  M. E. Bravo-Gómez,et al.  Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action. , 2017, Journal of inorganic biochemistry.

[4]  K. Goswami,et al.  Sulfonamide chalcones: Synthesis and in vitro exploration for therapeutic potential against Brugia malayi. , 2016, European journal of medicinal chemistry.

[5]  M. Dea-Ayuela,et al.  Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives. , 2016, European journal of medicinal chemistry.

[6]  Y. Tragoolpua,et al.  Propolis extracts from the northern region of Thailand suppress cancer cell growth through induction of apoptosis pathways , 2016, Investigational New Drugs.

[7]  Mingyao Liu,et al.  Synthesis of novel diterpenoid analogs with in-vivo antitumor activity. , 2016, European journal of medicinal chemistry.

[8]  李霞,et al.  N 12 -乙基取代吲哚咔唑衍生物的合成及细胞毒活性研究 , 2016 .

[9]  C. Jaffe,et al.  Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi. , 2016, Journal of natural products.

[10]  T. Ling,et al.  (+)-Dehydroabietylamine derivatives target triple-negative breast cancer. , 2015, European journal of medicinal chemistry.

[11]  Xiaolin Qin,et al.  Synthesis and antitumor activities of piperazine- and cyclen-conjugated dehydroabietylamine derivatives , 2015 .

[12]  Jisen Shi,et al.  High loading of doxorubicin into styrene-terminated porous silicon nanoparticles via π-stacking for cancer treatments in vitro , 2015 .

[13]  Miguel A. González.  Aromatic abietane diterpenoids: their biological activity and synthesis. , 2015, Natural product reports.

[14]  Miguel A. González.  Synthetic derivatives of aromatic abietane diterpenoids and their biological activities. , 2014, European journal of medicinal chemistry.

[15]  G. Robertson,et al.  Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine , 2014, Molecular Cancer Therapeutics.

[16]  Munirah Ahmad,et al.  Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes. , 2014, Metallomics : integrated biometal science.

[17]  V. Gandin,et al.  Advances in copper complexes as anticancer agents. , 2014, Chemical reviews.

[18]  Nisha Singh,et al.  Natural product based leads to fight against leishmaniasis. , 2014, Bioorganic & medicinal chemistry.

[19]  A. Powell,et al.  Synthesis, Crystal Structure, DNA Binding, Antibacterial, and Cytotoxic Activities of Two Chiral Copper(II) Complexes , 2013 .

[20]  Crispin R Dass,et al.  Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems , 2013, The Journal of pharmacy and pharmacology.

[21]  Zhan‐qian Song,et al.  Antitumor activity and structure-activity relationship of diterpenoids with a dehydroabietyl skeleton. , 2012, Combinatorial chemistry & high throughput screening.

[22]  Zhongxiang Lin,et al.  Synthesis and antitumour activities of a novel class of dehydroabietylamine derivatives , 2012, Natural product research.

[23]  N. Dharmaraj,et al.  Organometallic ruthenium(II) complexes: synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity. , 2012, European journal of medicinal chemistry.

[24]  Y. Bao,et al.  N-Benzoyl-12-nitrodehydroabietylamine-7-one, a novel dehydroabietylamine derivative, induces apoptosis and inhibits proliferation in HepG2 cells. , 2012, Chemico-biological interactions.

[25]  D. S. Raja,et al.  DNA binding, protein interaction, radical scavenging and cytotoxic activity of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde(2′-hydroxybenzoyl)hydrazone and its Cu(II) complexes: A structure activity relationship study , 2012 .

[26]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[27]  L. Yao,et al.  Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model. , 2011, Oncology letters.

[28]  O. Akhavan,et al.  CuO/Cu(OH) 2 hierarchical nanostructures as bactericidal photocatalysts , 2011 .

[29]  V. S. Periasamy,et al.  Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis. , 2011, Inorganic chemistry.

[30]  R. Berlinck,et al.  Current approaches to discover marine antileishmanial natural products. , 2011, Planta medica.

[31]  Bao-dui Wang,et al.  Crystal structures, DNA-binding and cytotoxic activities studies of Cu(II) complexes with 2-oxo-quinoline-3-carbaldehyde Schiff-bases. , 2010, European journal of medicinal chemistry.

[32]  M. E. Bravo-Gómez,et al.  Copper compounds in cancer chemotherapy. , 2010, Current medicinal chemistry.

[33]  E. Gao,et al.  Hairpin-shaped tetranuclear palladium(II) complex: synthesis, crystal structure, DNA binding and cytotoxicity activity studies. , 2010, European journal of medicinal chemistry.

[34]  F. Arcamone.  Fifty years of chemical research at Farmitalia. , 2009, Chemistry.

[35]  F. Arjmand,et al.  Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and zinc(II) complexes derived from 2,2,2('),2(')-S,S[bis(bis-N,N-2-thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies. , 2009, European journal of medicinal chemistry.

[36]  Yin Wu,et al.  Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression. , 2008, Cancer letters.

[37]  Zhanqian Song,et al.  Synthesis and antitumor activity of novel a-aminophosphonates from diterpenic dehydroabietylamine , 2008 .

[38]  V. S. Periasamy,et al.  Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity. , 2007, Inorganic chemistry.

[39]  Jen-kun Lin,et al.  Apoptosis of human melanoma cells induced by the novel compounds propolin A and propolin B from Taiwenese propolis. , 2007, Cancer letters.

[40]  K. Werbovetz,et al.  Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis. , 2006, Current medicinal chemistry.

[41]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[42]  F. Bunz,et al.  Cell death and cancer therapy. , 2001, Current opinion in pharmacology.

[43]  K. Hande.  Clinical applications of anticancer drugs targeted to topoisomerase II. , 1998, Biochimica et biophysica acta.

[44]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[45]  K. Bhalla,et al.  Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. , 1993, Leukemia.

[46]  S. Kaufmann.  Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. , 1989, Cancer research.